nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—ALB—focal segmental glomerulosclerosis	0.465	1	CbGaD
Rosiglitazone—SLCO1B1—Cyclosporine—focal segmental glomerulosclerosis	0.192	0.427	CbGbCtD
Rosiglitazone—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.0812	0.181	CbGbCtD
Rosiglitazone—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0681	0.151	CbGbCtD
Rosiglitazone—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0567	0.126	CbGbCtD
Rosiglitazone—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0518	0.115	CbGbCtD
Rosiglitazone—PPARG—nephron—focal segmental glomerulosclerosis	0.00737	0.3	CbGeAlD
Rosiglitazone—ACSL4—nephron tubule—focal segmental glomerulosclerosis	0.00354	0.144	CbGeAlD
Rosiglitazone—PPARG—endothelium—focal segmental glomerulosclerosis	0.00348	0.141	CbGeAlD
Rosiglitazone—ACSL4—cortex of kidney—focal segmental glomerulosclerosis	0.00303	0.123	CbGeAlD
Rosiglitazone—Hypertriglyceridaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.0629	CcSEcCtD
Rosiglitazone—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0622	CcSEcCtD
Rosiglitazone—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0622	CcSEcCtD
Rosiglitazone—Blood triglycerides increased—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.0552	CcSEcCtD
Rosiglitazone—ACSL4—Fatty Acid Beta Oxidation—LIPC—focal segmental glomerulosclerosis	0.00208	0.0984	CbGpPWpGaD
Rosiglitazone—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0501	CcSEcCtD
Rosiglitazone—ALB—Scavenging of heme from plasma—APOL1—focal segmental glomerulosclerosis	0.00188	0.0888	CbGpPWpGaD
Rosiglitazone—PTGS1—endothelium—focal segmental glomerulosclerosis	0.00186	0.0756	CbGeAlD
Rosiglitazone—SLCO1B1—kidney—focal segmental glomerulosclerosis	0.00162	0.066	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0397	CcSEcCtD
Rosiglitazone—PPARG—kidney—focal segmental glomerulosclerosis	0.0014	0.0569	CbGeAlD
Rosiglitazone—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.0343	CcSEcCtD
Rosiglitazone—ACSL4—Fatty Acid Beta Oxidation—LPL—focal segmental glomerulosclerosis	0.00127	0.06	CbGpPWpGaD
Rosiglitazone—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0302	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.03	CcSEcCtD
Rosiglitazone—PPARG—Adipogenesis—ZMPSTE24—focal segmental glomerulosclerosis	0.00115	0.0545	CbGpPWpGaD
Rosiglitazone—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0292	CcSEcCtD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—COL4A1—focal segmental glomerulosclerosis	0.00111	0.0526	CbGpPWpGaD
Rosiglitazone—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0011	0.0279	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0269	CcSEcCtD
Rosiglitazone—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.0269	CcSEcCtD
Rosiglitazone—CYP2C8—kidney—focal segmental glomerulosclerosis	0.000922	0.0375	CbGeAlD
Rosiglitazone—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000831	0.0211	CcSEcCtD
Rosiglitazone—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.000814	0.0206	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000806	0.0205	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000786	0.0199	CcSEcCtD
Rosiglitazone—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000781	0.0198	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000754	0.0191	CcSEcCtD
Rosiglitazone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOL1—focal segmental glomerulosclerosis	0.00075	0.0354	CbGpPWpGaD
Rosiglitazone—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000748	0.019	CcSEcCtD
Rosiglitazone—PTGS1—kidney—focal segmental glomerulosclerosis	0.000748	0.0304	CbGeAlD
Rosiglitazone—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000716	0.0181	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.0178	CcSEcCtD
Rosiglitazone—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000623	0.0158	CcSEcCtD
Rosiglitazone—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000615	0.025	CbGeAlD
Rosiglitazone—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000576	0.0146	CcSEcCtD
Rosiglitazone—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000569	0.0144	CcSEcCtD
Rosiglitazone—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000558	0.0141	CcSEcCtD
Rosiglitazone—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000538	0.0136	CcSEcCtD
Rosiglitazone—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.0134	CcSEcCtD
Rosiglitazone—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.0134	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.0129	CcSEcCtD
Rosiglitazone—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000508	0.0129	CcSEcCtD
Rosiglitazone—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000505	0.0128	CcSEcCtD
Rosiglitazone—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000499	0.0126	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000498	0.0126	CcSEcCtD
Rosiglitazone—SLCO1B1—Transport of organic anions—ALB—focal segmental glomerulosclerosis	0.000497	0.0235	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000483	0.0228	CbGpPWpGaD
Rosiglitazone—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000463	0.0117	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000439	0.0111	CcSEcCtD
Rosiglitazone—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000438	0.0111	CcSEcCtD
Rosiglitazone—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000435	0.011	CcSEcCtD
Rosiglitazone—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000404	0.0102	CcSEcCtD
Rosiglitazone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL4A1—focal segmental glomerulosclerosis	0.000386	0.0183	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Recycling of bile acids and salts—ALB—focal segmental glomerulosclerosis	0.000368	0.0174	CbGpPWpGaD
Rosiglitazone—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000365	0.00925	CcSEcCtD
Rosiglitazone—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00036	0.00912	CcSEcCtD
Rosiglitazone—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000348	0.00882	CcSEcCtD
Rosiglitazone—PTGS1—Overview of nanoparticle effects—FN1—focal segmental glomerulosclerosis	0.000344	0.0162	CbGpPWpGaD
Rosiglitazone—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000336	0.00853	CcSEcCtD
Rosiglitazone—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000321	0.00813	CcSEcCtD
Rosiglitazone—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00032	0.00812	CcSEcCtD
Rosiglitazone—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000319	0.00808	CcSEcCtD
Rosiglitazone—ALB—Lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000318	0.015	CbGpPWpGaD
Rosiglitazone—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.000311	0.0147	CbGpPWpGaD
Rosiglitazone—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000302	0.00766	CcSEcCtD
Rosiglitazone—ALB—Platelet degranulation—ACTN4—focal segmental glomerulosclerosis	0.000293	0.0139	CbGpPWpGaD
Rosiglitazone—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—focal segmental glomerulosclerosis	0.000292	0.0138	CbGpPWpGaD
Rosiglitazone—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	0.000287	0.0135	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—ACTN4—focal segmental glomerulosclerosis	0.000279	0.0132	CbGpPWpGaD
Rosiglitazone—PPARG—SREBP signalling—LPL—focal segmental glomerulosclerosis	0.000221	0.0105	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—CTGF—focal segmental glomerulosclerosis	0.00022	0.0104	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	0.000219	0.0103	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CTGF—focal segmental glomerulosclerosis	0.000215	0.0102	CbGpPWpGaD
Rosiglitazone—ALB—Lipid and lipoprotein metabolism—LIPC—focal segmental glomerulosclerosis	0.000211	0.00998	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—LPL—focal segmental glomerulosclerosis	0.000203	0.00958	CbGpPWpGaD
Rosiglitazone—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—focal segmental glomerulosclerosis	0.000201	0.00948	CbGpPWpGaD
Rosiglitazone—ALB—Lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000194	0.00916	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Bile acid and bile salt metabolism—ALB—focal segmental glomerulosclerosis	0.000193	0.0091	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000192	0.00909	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—focal segmental glomerulosclerosis	0.000184	0.00871	CbGpPWpGaD
Rosiglitazone—CYP2C19—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000184	0.00871	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MYH10—focal segmental glomerulosclerosis	0.000173	0.00815	CbGpPWpGaD
Rosiglitazone—CYP2D6—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.00017	0.00801	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—focal segmental glomerulosclerosis	0.000148	0.00701	CbGpPWpGaD
Rosiglitazone—CYP1A2—Melatonin metabolism and effects—EDN1—focal segmental glomerulosclerosis	0.000144	0.00679	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	0.000133	0.0063	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—LPL—focal segmental glomerulosclerosis	0.000133	0.0063	CbGpPWpGaD
Rosiglitazone—PPARG—PPARA activates gene expression—AGT—focal segmental glomerulosclerosis	0.00013	0.00616	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—ACTN4—focal segmental glomerulosclerosis	0.00013	0.00615	CbGpPWpGaD
Rosiglitazone—ALB—Lipid and lipoprotein metabolism—LPL—focal segmental glomerulosclerosis	0.000129	0.00609	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—COL4A4—focal segmental glomerulosclerosis	0.000128	0.00603	CbGpPWpGaD
Rosiglitazone—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—focal segmental glomerulosclerosis	0.000128	0.00603	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—GNAQ—focal segmental glomerulosclerosis	0.000125	0.00591	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—COL4A1—focal segmental glomerulosclerosis	0.000117	0.00554	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	0.000114	0.00539	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—AGT—focal segmental glomerulosclerosis	0.000114	0.00539	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—COL4A3—focal segmental glomerulosclerosis	9.91e-05	0.00468	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—LIPC—focal segmental glomerulosclerosis	9.73e-05	0.0046	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor—LPL—focal segmental glomerulosclerosis	9.63e-05	0.00455	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MYH9—focal segmental glomerulosclerosis	9.45e-05	0.00447	CbGpPWpGaD
Rosiglitazone—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	8.79e-05	0.00415	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—SERPINE1—focal segmental glomerulosclerosis	8.77e-05	0.00414	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.76e-05	0.00414	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—CTGF—focal segmental glomerulosclerosis	8.57e-05	0.00405	CbGpPWpGaD
Rosiglitazone—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—focal segmental glomerulosclerosis	8.42e-05	0.00398	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	8.39e-05	0.00397	CbGpPWpGaD
Rosiglitazone—PTGS1—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	8.38e-05	0.00396	CbGpPWpGaD
Rosiglitazone—ALB—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	8.34e-05	0.00394	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.89e-05	0.00373	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—NOS2—focal segmental glomerulosclerosis	7.35e-05	0.00347	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TRPC6—focal segmental glomerulosclerosis	7.29e-05	0.00344	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—CTGF—focal segmental glomerulosclerosis	7.02e-05	0.00332	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—FN1—focal segmental glomerulosclerosis	6.99e-05	0.0033	CbGpPWpGaD
Rosiglitazone—ALB—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	6.79e-05	0.00321	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	6.71e-05	0.00317	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—ACTN4—focal segmental glomerulosclerosis	6.7e-05	0.00317	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—FN1—focal segmental glomerulosclerosis	6.66e-05	0.00315	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TRPC6—focal segmental glomerulosclerosis	6.24e-05	0.00295	CbGpPWpGaD
Rosiglitazone—PPARG—Circadian rythm related genes—SERPINE1—focal segmental glomerulosclerosis	6.19e-05	0.00292	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—LPL—focal segmental glomerulosclerosis	5.94e-05	0.00281	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	5.9e-05	0.00279	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—SERPINE1—focal segmental glomerulosclerosis	5.82e-05	0.00275	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—focal segmental glomerulosclerosis	5.54e-05	0.00262	CbGpPWpGaD
Rosiglitazone—PPARG—Adipogenesis—TGFB1—focal segmental glomerulosclerosis	5.54e-05	0.00262	CbGpPWpGaD
Rosiglitazone—ALB—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	5.39e-05	0.00255	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	5.28e-05	0.0025	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—GNAQ—focal segmental glomerulosclerosis	5.22e-05	0.00246	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—AGT—focal segmental glomerulosclerosis	5.08e-05	0.0024	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	4.87e-05	0.0023	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	4.7e-05	0.00222	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.65e-05	0.0022	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—LPL—focal segmental glomerulosclerosis	4.58e-05	0.00217	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—ANGPT2—focal segmental glomerulosclerosis	4.49e-05	0.00212	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	4.14e-05	0.00195	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.09e-05	0.00193	CbGpPWpGaD
Rosiglitazone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—focal segmental glomerulosclerosis	4e-05	0.00189	CbGpPWpGaD
Rosiglitazone—SLCO1B1—SLC-mediated transmembrane transport—ALB—focal segmental glomerulosclerosis	3.96e-05	0.00187	CbGpPWpGaD
Rosiglitazone—ACSL4—Metabolism—ALB—focal segmental glomerulosclerosis	3.9e-05	0.00184	CbGpPWpGaD
Rosiglitazone—ALB—Platelet degranulation—TGFB1—focal segmental glomerulosclerosis	3.67e-05	0.00174	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.5e-05	0.00165	CbGpPWpGaD
Rosiglitazone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—focal segmental glomerulosclerosis	3.5e-05	0.00165	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—CTGF—focal segmental glomerulosclerosis	3.38e-05	0.0016	CbGpPWpGaD
Rosiglitazone—CYP2A6—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	3.34e-05	0.00158	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.22e-05	0.00152	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TRPC6—focal segmental glomerulosclerosis	3.22e-05	0.00152	CbGpPWpGaD
Rosiglitazone—PPARG—Generic Transcription Pathway—SERPINE1—focal segmental glomerulosclerosis	3.2e-05	0.00151	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—FN1—focal segmental glomerulosclerosis	3.1e-05	0.00147	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MMP2—focal segmental glomerulosclerosis	3.07e-05	0.00145	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.03e-05	0.00143	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	3.02e-05	0.00143	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—LIPC—focal segmental glomerulosclerosis	2.99e-05	0.00141	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.87e-05	0.00135	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	2.78e-05	0.00132	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.76e-05	0.0013	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.71e-05	0.00128	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—GNAQ—focal segmental glomerulosclerosis	2.69e-05	0.00127	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.69e-05	0.00127	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.67e-05	0.00126	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.66e-05	0.00126	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CTGF—focal segmental glomerulosclerosis	2.63e-05	0.00124	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	2.58e-05	0.00122	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.47e-05	0.00117	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.45e-05	0.00116	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.42e-05	0.00114	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.38e-05	0.00113	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.35e-05	0.00111	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—MMP9—focal segmental glomerulosclerosis	2.31e-05	0.00109	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	2.17e-05	0.00103	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.12e-05	0.001	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	2.11e-05	0.000997	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.09e-05	0.000989	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.07e-05	0.000978	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.01e-05	0.000951	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.98e-05	0.000935	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.91e-05	0.000901	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.9e-05	0.000899	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.88e-05	0.000889	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	1.86e-05	0.000878	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.85e-05	0.000875	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CTGF—focal segmental glomerulosclerosis	1.84e-05	0.00087	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.84e-05	0.00087	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—LPL—focal segmental glomerulosclerosis	1.82e-05	0.000861	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.74e-05	0.000823	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.7e-05	0.000802	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.65e-05	0.000781	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	1.63e-05	0.00077	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.6e-05	0.000758	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	1.6e-05	0.000755	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000749	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	1.58e-05	0.000747	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000744	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AGT—focal segmental glomerulosclerosis	1.56e-05	0.000737	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	1.54e-05	0.000729	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.51e-05	0.000712	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—LPL—focal segmental glomerulosclerosis	1.44e-05	0.000678	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.41e-05	0.000668	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LIPC—focal segmental glomerulosclerosis	1.35e-05	0.000639	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	1.34e-05	0.000635	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	1.33e-05	0.000629	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.29e-05	0.000609	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	1.29e-05	0.000609	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	1.28e-05	0.000603	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AGT—focal segmental glomerulosclerosis	1.23e-05	0.00058	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.22e-05	0.000574	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—LPL—focal segmental glomerulosclerosis	1.21e-05	0.000571	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	1.21e-05	0.00057	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—focal segmental glomerulosclerosis	1.2e-05	0.000565	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CTGF—focal segmental glomerulosclerosis	1.19e-05	0.000562	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	1.18e-05	0.000559	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	1.11e-05	0.000524	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	1.1e-05	0.000521	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	1.1e-05	0.00052	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.1e-05	0.000518	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	1.09e-05	0.000516	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.09e-05	0.000515	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.09e-05	0.000513	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	1.06e-05	0.000502	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AGT—focal segmental glomerulosclerosis	1.03e-05	0.000488	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	9.9e-06	0.000468	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	9.79e-06	0.000462	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	9.77e-06	0.000462	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	9.68e-06	0.000458	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—focal segmental glomerulosclerosis	9.42e-06	0.000445	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	9.4e-06	0.000444	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	9e-06	0.000425	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	8.92e-06	0.000422	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	8.46e-06	0.0004	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	8.4e-06	0.000397	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	8.38e-06	0.000396	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	8.28e-06	0.000391	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—LPL—focal segmental glomerulosclerosis	8.25e-06	0.00039	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	8.2e-06	0.000387	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—focal segmental glomerulosclerosis	7.93e-06	0.000375	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.62e-06	0.00036	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	7.36e-06	0.000348	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AGT—focal segmental glomerulosclerosis	7.06e-06	0.000333	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	7.02e-06	0.000331	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	6.77e-06	0.00032	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	6.71e-06	0.000317	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	6.3e-06	0.000298	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	5.79e-06	0.000274	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	5.74e-06	0.000271	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	5.74e-06	0.000271	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—focal segmental glomerulosclerosis	5.41e-06	0.000256	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	4.91e-06	0.000232	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	4.83e-06	0.000228	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	4.45e-06	0.00021	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	4.41e-06	0.000208	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	3.77e-06	0.000178	CbGpPWpGaD
